Filed Pursuant to Rule 424(b)(5)
Registration Statement No. 333-236018
PROSPECTUS SUPPLEMENT
(To Prospectus dated June 25, 2020)
2,100,000 Depositary Shares, each representing a 1/40th Interest in a Share of
7.125% Series A Fixed-Rate Non-Cumulative Perpetual Preferred Stock
We are offering 2,100,000 depositary shares, each representing a 1/40th ownership interest in a share of 7.125% Series A Fixed-Rate Non-Cumulative Perpetual Preferred Stock, no par value per share, with a liquidation preference of $1,000 per share (equivalent to $25 per depositary share) (the “Preferred Stock”). As a holder of depositary shares, you will be entitled to all proportional rights and preferences of the Preferred Stock (including dividend, voting, redemption, liquidation and other rights). You must exercise such rights through American Stock Transfer & Trust Company, LLC, as the depositary for the shares of the Preferred Stock.
We will pay dividends on the Preferred Stock, when, as, and if declared by our board of directors or a duly authorized committee of our board of directors, to the extent that we have lawfully available funds to pay dividends. From the issue date, dividends on the Preferred Stock will accrue on a non-cumulative basis at a rate of 7.125% per annum on the liquidation preference of $1,000 per share, payable quarterly, in arrears, on the 1st day of each of March, June, September and December, commencing on December 1, 2020.
Dividends on the Preferred Stock will not be cumulative. If for any reason our board of directors or a duly authorized committee of our board of directors does not declare a dividend on the Preferred Stock for any dividend period, that dividend will not accrue or be payable and we will have no obligation to pay dividends for that dividend period, whether or not dividends on the Preferred Stock are declared for any future dividend period.
The Preferred Stock is perpetual and has no maturity date. We may redeem the Preferred Stock at our option, (i) in whole or in part, from time to time, on any dividend payment date on or after September 1, 2025 at a redemption price equal to $1,000 per share (equivalent to $25 per depositary share), plus any declared and unpaid dividends, without accumulation of any undeclared and unpaid dividends, to, but excluding, the redemption date, or (ii) in whole but not in part, at any time within 90 days following a regulatory capital treatment event (as defined herein), at a redemption price equal to $1,000 per share (equivalent to $25 per depositary share), plus any declared and unpaid dividends, without accumulation of any undeclared and unpaid dividends, to, but excluding, the redemption date. If we redeem the Preferred Stock, the depositary is expected to redeem a proportionate number of depositary shares. Neither the holders of Preferred Stock nor holders of depositary shares will have the right to require the redemption or repurchase of the Preferred Stock or the depositary shares. Any redemption of the Preferred Stock is subject to our receipt of any required prior approval by the Board of Governors of the Federal Reserve System (the “Federal Reserve”) or other successor regulatory authority.
The Preferred Stock will not have any voting rights, except as set forth under “Description of the Preferred Stock—Voting Rights” and “Description of the Preferred Stock—Other Voting Rights” beginning on page S-24.
We have filed an application to list the depositary shares on the NASDAQ Global Select Market (“NASDAQ”) under the symbol “CCNEP.” If the application is approved, trading of the depositary shares on NASDAQ is expected to begin within 30 days after the date of initial issuance of the depositary shares. Our common stock is listed on NASDAQ and trades under the ticker symbol “CCNE.”
Investing in the depositary shares involves risk. You should refer to “Risk Factors” beginning on page S-15 of this prospectus supplement, as well as those risk factors contained in our reports filed with the Securities & Exchange Commission (“SEC”), which are incorporated, or deemed to be incorporated, by reference into this prospectus supplement.
| | | | | | | | |
| | Per Depositary Share | | | Total | |
Public offering price(1) | | $ | 25.00 | | | $ | 52,500,000 | |
Underwriting discount and commissions(2) | | $ | 0.7875 | | | $ | 1,653,750 | |
Proceeds to CNB Financial Corporation before expenses | | $ | 24.2125 | | | $ | 50,846,250 | |
(1) | Plus accrued dividends, if any, from the date of initial issuance, which is expected to be August 25, 2020. |
(2) | See “Underwriting” in this prospectus supplement for details regarding compensation to be received by the underwriters in connection with this offering. |
(3) | Assumes no exercise of the underwriters’ option to purchase additional depositary shares described below. |
We have granted the underwriters an option to purchase up to an additional 315,000 depositary shares within 30 days after the date of this prospectus supplement at the public offering price, less underwriting discounts and commissions.
None of the SEC, any state securities commission, the Board of Governors of the Federal Reserve System, the Federal Deposit Insurance Corporation (“FDIC”) or any other regulatory body has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense.
The depositary shares are not savings accounts, deposits or obligations of any bank or non- bank subsidiary of CNB Financial Corporation and are not insured or guaranteed by the FDIC or any other governmental agency.
The underwriters expect to deliver the depositary shares in book-entry form only through the facilities of The Depositary Trust Company and its direct participants, including Euroclear Bank S.A./N.V., as operator of the Euroclear System (“Euroclear”), and Clearstream Banking, a société anonyme (“Clearstream”), on or about August 25, 2020.
Joint Book-Running Managers
| | | | |
Janney Montgomery Scott | | | | Boenning & Scattergood |
Co-Managers
| | | | |
William Blair | | | | Hovde Group, LLC |
The date of this prospectus supplement is August 20, 2020.